• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体切除术治疗持续性弥漫性糖尿病性黄斑水肿。

Vitrectomy for persistent diffuse diabetic macular edema.

作者信息

Stolba Ulrike, Binder Susanne, Gruber Diego, Krebs Ilse, Aggermann Tina, Neumaier Beatrix

机构信息

Department of Ophthalmology, Rudolf Foundation Clinic, Vienna, Austria.

出版信息

Am J Ophthalmol. 2005 Aug;140(2):295-301. doi: 10.1016/j.ajo.2005.03.045.

DOI:10.1016/j.ajo.2005.03.045
PMID:16023067
Abstract

PURPOSE

To evaluate the potential benefit of vitrectomy in eyes with persistent diffuse macular edema.

DESIGN

Prospective randomized comparative clinical trial.

METHODS

Eyes with diffuse diabetic macular edema for 6 to 18 months, an attached posterior hyaloid, and grid laser photocoagulation performed at least 4 months before were included. Patients were randomized either to a vitrectomy group or to a control group.

MAIN OUTCOME MEASURES

Evaluations of Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity, reading vision, and retinal thickness were carried out at baseline and 1, 3, and 6 months after enrollment.

RESULTS

Fifty-six eyes (100%) were enrolled in this study. Twenty-five eyes (44.6%) were randomized into Gr I (vitrectomy group) and 31 eyes (55.4%) into Gr II (controls). Both groups were comparable in mean age (62.7 years and 63.9 years) and distribution of gender (one third male, two thirds female). ETDRS visual acuity showed a statistical significance in favor of Gr I at all time points (P = .035 to .005 Fisher's exact test). With Jaeger charts a significance for Gr I was found only at the 6-month examination (P = .01). With optical coherence tomography, the different behavior of retinal thickness changes in both groups during follow-up was statistically significant; P values were <.0001 for month 1, 3, and 6, preferring Gr I.

CONCLUSIONS

We provide evidence that vitrectomy with internal limiting membrane peeling is superior to observation alone in eyes with persistent diffuse diabetic macular edema for 6 to 18 months. Longer follow-up periods and larger series might be needed to confirm these results and gain additional information.

摘要

目的

评估玻璃体切除术对持续性弥漫性黄斑水肿患者的潜在益处。

设计

前瞻性随机对照临床试验。

方法

纳入患有弥漫性糖尿病性黄斑水肿6至18个月、后玻璃体附着且至少在4个月前已进行格栅样激光光凝的患者。患者被随机分为玻璃体切除组或对照组。

主要观察指标

在基线以及入组后1、3和6个月对糖尿病视网膜病变早期治疗研究(ETDRS)视力、阅读视力和视网膜厚度进行评估。

结果

本研究共纳入56只眼(100%)。25只眼(44.6%)被随机分为I组(玻璃体切除组),31只眼(55.4%)被分为II组(对照组)。两组在平均年龄(62.7岁和63.9岁)和性别分布(三分之一为男性,三分之二为女性)方面具有可比性。ETDRS视力在所有时间点均显示I组具有统计学意义(P = 0.035至0.005,Fisher精确检验)。使用耶格视力表,仅在6个月检查时发现I组具有统计学意义(P = 0.01)。通过光学相干断层扫描,两组在随访期间视网膜厚度变化的不同表现具有统计学意义;第1、3和6个月的P值均<0.0001,I组更具优势。

结论

我们提供的证据表明,对于患有持续性弥漫性糖尿病性黄斑水肿6至18个月的患者,玻璃体切除联合内界膜剥除术优于单纯观察。可能需要更长的随访期和更大的样本量来证实这些结果并获取更多信息。

相似文献

1
Vitrectomy for persistent diffuse diabetic macular edema.玻璃体切除术治疗持续性弥漫性糖尿病性黄斑水肿。
Am J Ophthalmol. 2005 Aug;140(2):295-301. doi: 10.1016/j.ajo.2005.03.045.
2
Pars plana vitrectomy with removal of the internal limiting membrane in the treatment of persistent diabetic macular edema.玻璃体切割联合内界膜剥除术治疗持续性糖尿病性黄斑水肿
Am J Ophthalmol. 2005 Mar;139(3):447-54. doi: 10.1016/j.ajo.2004.09.076.
3
Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.改良格栅激光光凝术与玻璃体切割联合内界膜剥除术治疗糖尿病性黄斑水肿的比较
Am J Ophthalmol. 2005 May;139(5):795-801. doi: 10.1016/j.ajo.2004.12.017.
4
Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.微视野计和眼底自发荧光在糖尿病性黄斑水肿中的应用:阈下微脉冲二极管激光与改良早期治疗糖尿病性视网膜病变研究激光光凝比较。
Retina. 2010 Jun;30(6):908-16. doi: 10.1097/IAE.0b013e3181c96986.
5
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.玻璃体后皮质切除术联合内界膜剥除术治疗糖尿病性黄斑水肿
Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.
6
[Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].糖尿病性黄斑水肿眼行玻璃体切除术联合视网膜内界膜(ILM)剥除术
Klin Oczna. 2006;108(7-9):273-7.
7
Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular edema.玻璃体内注射曲安奈德联合黄斑激光治疗弥漫性糖尿病性黄斑水肿后的玻璃体后界膜改变
Retina. 2008 Nov-Dec;28(10):1435-42. doi: 10.1097/IAE.0b013e31817f2dae.
8
The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema.格栅样激光光凝术后光学相干断层扫描对弥漫性糖尿病性黄斑水肿的预测价值
Acta Ophthalmol. 2008 May;86(3):284-91. doi: 10.1111/j.1600-0420.2007.01048.x. Epub 2007 Nov 13.
9
Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane.手术切除后玻璃体膜和内界膜后糖尿病性黄斑水肿的消退
Retina. 2000;20(2):126-33.
10
[Is removal of internal limiting membrane always necessary during surgery for refractory diffuse diabetic macular edema without evident epimacular proliferation?].[在治疗无明显黄斑前增殖的难治性弥漫性糖尿病性黄斑水肿的手术中,是否总是需要剥除内界膜?]
Klin Monbl Augenheilkd. 2006 Aug;223(8):681-6. doi: 10.1055/s-2006-926606.

引用本文的文献

1
Diabetic Macular Oedema Guidelines: An Australian Perspective.糖尿病性黄斑水肿指南:澳大利亚视角
J Ophthalmol. 2023 Feb 14;2023:6329819. doi: 10.1155/2023/6329819. eCollection 2023.
2
The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.日本增生型糖尿病视网膜病变患者玻璃体切除术后不同降糖方案与术后糖尿病性黄斑水肿的关系。
Front Endocrinol (Lausanne). 2022 Jul 22;13:764254. doi: 10.3389/fendo.2022.764254. eCollection 2022.
3
Effect of vitrectomy with silicone oil tamponade and internal limiting membrane peeling on eyes with proliferative diabetic retinopathy.
玻璃体切割联合硅油填充和内界膜剥除治疗增生性糖尿病视网膜病变。
Sci Rep. 2022 May 16;12(1):8076. doi: 10.1038/s41598-022-12113-8.
4
Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye.玻璃体内注射组织型纤溶酶原激活剂治疗玻璃体切割术后难治性糖尿病性黄斑水肿
Case Rep Ophthalmol. 2021 Oct 11;12(3):841-847. doi: 10.1159/000518289. eCollection 2021 Sep-Dec.
5
Surgical outcomes of vitrectomy for intractable diabetic macular edema.玻璃体切割术治疗难治性糖尿病黄斑水肿的手术效果。
Graefes Arch Clin Exp Ophthalmol. 2021 Feb;259(2):363-368. doi: 10.1007/s00417-020-04898-z. Epub 2020 Aug 20.
6
The Evolving Treatment of Diabetic Retinopathy.糖尿病视网膜病变的治疗进展
Clin Ophthalmol. 2020 Mar 4;14:653-678. doi: 10.2147/OPTH.S236637. eCollection 2020.
7
Revisiting pars plana vitrectomy in the primary treatment of diabetic macular edema in the era of pharmacological treatment.在药物治疗时代重新审视玻璃体切割术在糖尿病性黄斑水肿初始治疗中的应用
Taiwan J Ophthalmol. 2019 Dec 13;9(4):224-232. doi: 10.4103/tjo.tjo_61_19. eCollection 2019 Oct-Dec.
8
Submacular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema.玻璃体内注射雷珠单抗作为难治性糖尿病性黄斑水肿的一种新的手术治疗方法
J Ophthalmol. 2019 Oct 21;2019:6274209. doi: 10.1155/2019/6274209. eCollection 2019.
9
Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitis.玻璃体黄斑粘连对非感染性葡萄膜炎STOP-葡萄膜炎临床试验治疗结果的影响。
J Ophthalmic Inflamm Infect. 2019 Jul 19;9(1):12. doi: 10.1186/s12348-019-0179-6.
10
Vitrectomy Combined with Intraoperative Dexamethasone Implant for the Management of Refractory Diabetic Macular Edema.玻璃体切除术联合术中地塞米松植入治疗难治性糖尿病性黄斑水肿
Korean J Ophthalmol. 2019 Jun;33(3):249-258. doi: 10.3341/kjo.2018.0100.